Hepatocellular carcinoma (HCC)
Showing 1 - 25 of 9,731
Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- EYE90 Microspheres Treatment
- (no location specified)
Jul 12, 2023
Early Diagnosis of Hepatocellular Carcinoma (HCC)
Recruiting
- HCC
- +4 more
- Biomarker dosage
-
Castellana Grotte, Bari, ItalyRCCS "Saverio de Bellis"
Mar 23, 2023
Hepatocellular Carcinoma Non-resectable Trial in Belgium, Germany, Italy (BioPearl™)
Not yet recruiting
- Hepatocellular Carcinoma Non-resectable
- BioPearl™
-
Brussels, Belgium
- +5 more
Jun 20, 2023
Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)
Not yet recruiting
- Hepatocellular Carcinoma
- Livmoniplimab
- +5 more
- (no location specified)
Oct 26, 2023
Hepatocellular Carcinoma Trial in Munich, Würzburg (durvalumab, tremelimumab, bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- durvalumab, tremelimumab, bevacizumab
-
Munich, Germany
- +2 more
May 3, 2023
Unresectable Hepatocellular Carcinoma (HCC) Trial in Milano, Rozzano, Barcelona (NMS-01940153E)
Recruiting
- Unresectable Hepatocellular Carcinoma (HCC)
-
Milano, Italy
- +2 more
Dec 2, 2022
Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation
Recruiting
- Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Jan 4, 2023
Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma Trial run by the NCI (Cyclophosphamide,
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Cyclophosphamide
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)
Recruiting
- Hepatocellular Carcinoma (HCC)
-
Kaohsiung, Taiwan
- +4 more
Mar 14, 2023
Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,
Active, not recruiting
- Radiomics
- +4 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023
Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))
Not yet recruiting
- Hepatocellular Carcinoma (HCC)
- Durvalumab
- +2 more
- (no location specified)
Sep 11, 2023
Hepatocellular Carcinoma Trial in Roma (multimodal ultrasound)
Recruiting
- Hepatocellular Carcinoma
- multimodal ultrasound
-
Roma, ItalyFondazione Policlinico Gemelli IRCCS
Aug 3, 2023
HepaSphere Drug-eluting Bead Transarterial Chemoembolization
Recruiting
- Advanced Hepatocellular Carcinoma (HCC)
- DEB-TACE plus HAIC or HAIC alone
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
May 19, 2023
Hepatocellular Carcinoma Trial in Shanghai (Ori-C101)
Recruiting
- Hepatocellular Carcinoma
- Ori-C101
-
Shanghai, ChinaZhongshan Hospital Fudan University
Dec 21, 2022
Chronic Liver Disease, Hepatocellular Carcinoma (HCC) Trial in Toronto (13C Sodium Octanoate)
Terminated
- Chronic Liver Disease
- Hepatocellular Carcinoma (HCC)
- 13C Sodium Octanoate
-
Toronto, Ontario, CanadaToronto General Hospital
Dec 19, 2022
ALBI and PALBI Scores and HCC Prognosis
Completed
- Hepatocellular Carcinoma (HCC) Prognosis
- ALBI
-
Sohag, EgyptSohag University
Jan 30, 2023
Detect and Expunge Concealed Tumors of the Liver
Recruiting
- Liver Cancer
-
Hanoi, Vietnam108 Military Central Hospital
Nov 15, 2023
Systemic Therapies for Hepatocellular Carcinoma(HCC)
Enrolling by invitation
- Hepatocellular Carcinoma Non-resectable
- Effect of Drug
- radiological evaluation
-
Wenzhou, Zhejiang, ChinaGang Chen
Sep 14, 2022
HCC, Liver Cirrhosis Trial (sequential adult left lateral lobe liver transplantation (SALT))
Not yet recruiting
- HCC
- Liver Cirrhosis
- sequential adult left lateral lobe liver transplantation (SALT)
- (no location specified)
Oct 3, 2023
Hepatocellular Carcinoma Trial in Heidelberg (Carbon Ion Radiotherapy)
Terminated
- Hepatocellular Carcinoma
- Carbon Ion Radiotherapy
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Nov 2, 2022
Hepatocellular Carcinoma Trial in United States (Y-90 TARE, Atezolizumab, Bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- Y-90 TARE
- +2 more
-
Washington, District of Columbia
- +5 more
Jan 18, 2023
Hepatocellular Carcinoma Non-resectable, Metastatic Colorectal Cancer, Liver Cancer Trial in Grafton (Eye90 Microspheres)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- +2 more
- Eye90 Microspheres
-
Grafton, New ZealandAuckland District Health Board
Jan 30, 2023
Hepatocellular Carcinoma Non-resectable Trial in France (Lenvatinib)
Not yet recruiting
- Hepatocellular Carcinoma Non-resectable
-
Bordeaux, France
- +5 more
Jun 12, 2023
Hepatocellular Carcinoma Trial in Hershey (Lumason)
Completed
- Hepatocellular Carcinoma
-
Hershey, PennsylvaniaPenn State Hershey Medical Center
Oct 17, 2022